ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BSGM BioSig Technologies Inc

0.66
-0.07 (-9.59%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 272,267
Bid Price 0.65
Ask Price 0.73
News -
Day High 0.77

Low
0.2619

52 Week Range

High
16.50

Day Low 0.6501
Company Name Stock Ticker Symbol Market Type
BioSig Technologies Inc BSGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -9.59% 0.66 19:42:04
Open Price Low Price High Price Close Price Prev Close
0.739 0.6501 0.77 0.661 0.73
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
881 272,267 $ 0.7010532 $ 190,874 - 0.2619 - 16.50
Last Trade Time Type Quantity Stock Price Currency
19:42:04 formt 100 $ 0.66 USD

BioSig Technologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.44M 9.33M - 286k -27.27M -2.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioSig Technologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BSGM Message Board. Create One! See More Posts on BSGM Message Board See More Message Board Posts

Historical BSGM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.51810.770.45550.6340649125,2650.141927.39%
1 Month0.750.780.45550.6215714174,797-0.09-12.00%
3 Months4.3514.4990.26191.04476,678-3.69-84.83%
6 Months5.0786.800.26192.30385,220-4.42-87.00%
1 Year11.3016.500.26197.65452,583-10.64-94.16%
3 Years43.2049.000.261913.30350,217-42.54-98.47%
5 Years59.50124.300.261937.41372,917-58.84-98.89%

BioSig Technologies Description

BioSig Technologiesis an advanced medical technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare¿s biggest priorities-saving time, saving costs, and saving lives. The Company¿s first product, the PURE EP¿ System, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate.

Your Recent History

Delayed Upgrade Clock